About DNAnexus
DNAnexus news and updates
The Blackstone Group invests into DNAnexus Inc. in $200M
Michelle F Davis / Bloomberg:DNAnexus, a cloud service that helps researchers access and analyze genomic data, raises $200M led by Blackstone, sources say at a $600M valuationBioinformatics company DNAnexus Inc. has raised $200 million in a financing round led by Blackstone Inc. funds.
Jan 1, 2022 | latestnigeriannews.comDNAnexus Inc. received financing of $200M in funding round on Mar 8th 22'.
DNAnexus Inc., whose cloud software helps researchers analyze human genome data, said Tuesday it's raised $200 million in new funding.
Jan 1, 2022 | bizjournals.comBlackstonegroup invests into DNAnexus Inc. in $200M
Blackstone Growth has led a $200m financing round in cloud-based biomedical data analysis software DNAnexus.
Jan 1, 2022 | altassets.netDNAnexus Inc. partners with U.S. Food and Drug Administration
+ DNAnexus also exclusively partnered with the FDA to power precisionFDA, a secure, cloud-based, high-performance platform enabling access by FDA researchers and reviewers, as well as sponsors from the private sector, to use the data and tools in a collaborative environment, furthering the standards by which multi-omic data is included in FDA submissions.
Jan 1, 2022 | svdaily.comDNAnexus Inc. received financing of $200M in financing round on Jun 23rd 17'.
DNAnexus, Inc., a leading provider of cloud-based biomedical data analysis software serving the life sciences community, today announced a $200 million financing round to accelerate the global adoption of its technology, translating the world’s complex multi-omics and clinical data into tangible insights and personalized treatments.
Jan 1, 2017 | blackstone.comDNAnexus Inc. launched version 1.0 of htsget on Jan 1st 17'.
DNAnexus Inc. is especially pleased this year to join in launching version 1.0 of htsget, a new protocol for the secure web delivery of large genomic datasets, especially whole-genome sequencing reads which can exceed 100 gigabytes per person.
Jan 1, 2017 | dnanexus.comDNAnexus Inc. recognized as Best Workplaces for Innovators list on Feb 8th 22'.
DNAnexus, Inc., a leading provider of cloud-based biomedical data analysis platform serving the life sciences community, today announced that it was included in Fast Company's fourth annual Best Workplaces for Innovators list, honoring organizations and businesses that demonstrate a steadfast commitment to encouraging innovation at all levels.
Jan 1, 2022 | cmocro.comDNAnexus Inc. launches Case Management Portal
To solve these challenges, DNAnexus Inc. is excited to introduce the Case Management Portal – a powerful new solution built for sequencing service providers and diagnostic companies to monitor data analysis throughout the bioinformatics process, and automate critical workflow steps.
Nov 3, 2020 | dnanexus.comDNAnexus Inc. launches design refresh of the DNAnexus web user interface
DNAnexus Inc. is pleased to announce a design refresh of the DNAnexus web user interface!
Jul 17, 2017 | dnanexus.comDNAnexus Inc. hired Stephen Nuckols as chief commercial officer on Sep 23rd 22'.
DNAnexus has named Stephen Nuckols chief commercial officer to direct the company's growth strategy, sales, and marketing efforts following a $200 million financing round that closed earlier this year.
Sep 23, 2022 | genomeweb.comMyriad Genetics partners with DNAnexus Inc.
Myriad Genetics is collaborating with partners such as Illumina, Intermountain Healthcare, AstraZeneca, MSD and DNANexus, to name a few.
Sep 26, 2022 | myriad.comHealth Data Research UK website partners with DNAnexus Inc.
HDR UK are partnering with DNAnexus to demystify the concept of RAPs and provide an overview of some of the computational tools and methods that make building RAPs easier.
Oct 19, 2022 | hdruk.ac.ukDNAnexus Inc. hires Jeff Margolis as board of directors
DNAnexus has appointed Jeff Margolis to its board of directors.
Oct 20, 2022 | genomeweb.comGV invests into DNAnexus Inc.
Investors in DNAnexus’ latest funding round include GV (formerly Google Ventures), Foresite Capital, TPG Capital, First Round Capital, and first-time equity investor Regeneron Pharmaceuticals.
Jun 9, 2020 | venturebeat.com